Evoq Remedies Ltd — Board Meeting, 18-04-2025: Board Meeting

Evoq Remedies Limited's Board of Directors has announced a board meeting on 25th April 2025 to discuss the issuance of equity shares through a preferential issue aimed at acquiring up to 51% of Poshan Nutriwell Private Limited. The company is also considering raising funds of up to ₹99 Crores via convertible warrants through a preferential allotment to non-promoter entities. This strategic move could enhance Evoq's market position and expand its operations. However, investor sentiment may hinge on shareholder approval and potential dilution of existing shares, presenting both opportunities and risks ahead.